- Home
- GALT vs PNTG Comparison
GALT vs PNTG Comparison
Compare GALT & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- PNTG
- Stock Information
- Founded
- GALT 2000
- PNTG 2019
- Country
- GALT United States
- PNTG United States
- Employees
- GALT N/A
- PNTG N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- PNTG Medical/Nursing Services
- Sector
- GALT Health Care
- PNTG Health Care
- Exchange
- GALT Nasdaq
- PNTG Nasdaq
- Market Cap
- GALT 83.5M
- PNTG 805.7M
- IPO Year
- GALT N/A
- PNTG N/A
- Fundamental
- Price
- GALT $2.18
- PNTG $26.30
- Analyst Decision
- GALT Buy
- PNTG Buy
- Analyst Count
- GALT 2
- PNTG 6
- Target Price
- GALT $6.00
- PNTG $35.17
- AVG Volume (30 Days)
- GALT 1.4M
- PNTG 284.0K
- Earning Date
- GALT 08-12-2025
- PNTG 08-05-2025
- Dividend Yield
- GALT N/A
- PNTG N/A
- EPS Growth
- GALT N/A
- PNTG 40.99
- EPS
- GALT N/A
- PNTG 0.76
- Revenue
- GALT N/A
- PNTG $748,167,000.00
- Revenue This Year
- GALT N/A
- PNTG $25.01
- Revenue Next Year
- GALT N/A
- PNTG $8.19
- P/E Ratio
- GALT N/A
- PNTG $34.54
- Revenue Growth
- GALT N/A
- PNTG 30.04
- 52 Week Low
- GALT $0.73
- PNTG $21.18
- 52 Week High
- GALT $3.90
- PNTG $37.13
- Technical
- Relative Strength Index (RSI)
- GALT 56.31
- PNTG 37.58
- Support Level
- GALT $2.08
- PNTG $25.43
- Resistance Level
- GALT $2.66
- PNTG $30.21
- Average True Range (ATR)
- GALT 0.53
- PNTG 1.12
- MACD
- GALT -0.02
- PNTG -0.30
- Stochastic Oscillator
- GALT 33.09
- PNTG 16.44
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.